Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Juan Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, Acute Kidney Injury, NF-E2-Related Factor 2. Die Arbeit nennt 55 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Ferroptosis is a non‐regulatory cell death closely related to the process of cisplatin‐induced acute kidney injury (AKI). We sought to explore the ability of inhibited Interferon‐induced protein 35 (IFI35) to alleviate cisplatin‐induced AKI by modulating ferroptosis. Expression of IFI35 was investigated in the cisplatin‐induced AKI mouse model and cisplatin‐induced HK2 cells. The potential molecular mechanisms were examined in cells by detecting ferroptosis‐related indicators following the addition of ferroptosis inducer (Erastin) and the antioxidant transcription factor NRF2 pathway inhibitor (ML385), respectively. Higher levels of IFI35 were observed in AKI mouse model and HK2 cells. IFI35 deficiency enhanced cell viability and antioxidant capacity, reducing ferroptosis‐related parameters like Fe 2+ accumulation and ROS production while upregulating GPX4 and FSP1 protein levels. In mice, IFI35 blockade attenuated cisplatin‐induced renal injury, as evidenced by decreased serum urea nitrogen and creatinine levels, and improved histopathological changes. Mechanistically, IFI35 inhibition reduced peroxide production, reversed iron‐dependent mitochondrial damage, and inhibited ferroptosis via upregulating NRF2 activity. Our study suggested that IFI35 inhibition inhibits ferroptosis in AKI by upregulating NRF2 expression, targeting IFI35 may offer a promising therapeutic option for AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China.
- Department of Nephrology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China.
ORCID-Profile: Fang Sun
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Zhou, J., Liu, Y., & Sun, F. (2025). Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70383
Vancouver
Zhou J, Liu Y, Sun F. Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70383
BibTeX
@article{Zhou2025,
author = {Zhou, Juan and Liu, Ye and Sun, Fang},
title = {Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70383}
}
EUVIMED